Ikarian Capital, LLC Finch Therapeutics Group, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.75 - $51.3 $162,697 - $4.77 Million	-92,970 Reduced 28.13%	237,553 $397,000
Q1 2022 May 13, 2022	BUY	$5.02 - $10.47 $74,250 - $154,861	14,791 Added 4.68%	330,523 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$12.2 - $16.75 $113,069 - $155,239	-9,268 Reduced 2.85%	315,732 $4.11 Million
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $2.11 Million - $3.06 Million	175,000 Added 116.67%	325,000 $4.57 Million
Q1 2021 May 17, 2021	BUY	$15.54 - $21.32 $2.33 Million - $3.2 Million	150,000 New	150,000 $2.39 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $575M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.